Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.5 - $8.96 $731,740 - $1.46 Million
-162,609 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$7.08 - $8.88 $41,389 - $51,912
5,846 Added 3.73%
162,609 $1.42 Million
Q4 2021

Feb 14, 2022

BUY
$7.09 - $8.7 $1.11 Million - $1.36 Million
156,763 New
156,763 $1.21 Million

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $162M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.